Regarding MZF1, probably one of the most successful scenarios could be to inhibit its association with its specific co-transcription factors such as Elk1, which is needed for MZF1-induced activation of the expression of PRKCA and IGF1R, and which contributes to the stability of MZF1 in triple-negative breast cancer [24]. This evidence concerns the gene ELK1 and triple-negative breast carcinoma.